Clinical Trial Update: A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating recombinant human chorionic gonadotropin (Ovidrel) for inducing final follicle maturation and early luteinization in Chinese women unde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Ovidrel (Choriogonadotropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Phase 3 | Status: COMPLETED